{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:05:49Z","timestamp":1783595149080,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","issue":"11","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"One lambda\u00ae"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/tri.13009","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T13:59:45Z","timestamp":1499435985000},"page":"1150-1160","source":"Crossref","is-referenced-by-count":36,"title":["Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study"],"prefix":"10.3389","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-7722","authenticated-orcid":false,"given":"Clement","family":"Deltombe","sequence":"first","affiliation":[{"name":"Institute for Transplantation, Urology and Nephrology (ITUN); Nantes University Hospital; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Gillaizeau","sequence":"additional","affiliation":[{"name":"Institute for Transplantation, Urology and Nephrology (ITUN); Nantes University Hospital; Nantes France"},{"name":"Inserm U1064; Nantes University Hospital; Nantes France"},{"name":"EA 4275 SPHERE; Nantes University; Nantes France"},{"name":"LabEx Transplantex; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Anglicheau","sequence":"additional","affiliation":[{"name":"LabEx Transplantex; Nantes France"},{"name":"Thematic Research and Care Network RTRS \u201cCentaure\u201d; Universit\u00e9 de Strasbourg; Strasbourg France"},{"name":"Department of Kidney Transplantation; Necker University Hospital; AP-HP; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[{"name":"Thematic Research and Care Network RTRS \u201cCentaure\u201d; Universit\u00e9 de Strasbourg; Strasbourg France"},{"name":"Department of Transplantation and Clinical Immunology; Hospices Civils de Lyon; Hopital Edouard Herriot; Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Tr\u00e9bern-Launay","sequence":"additional","affiliation":[{"name":"Institute for Transplantation, Urology and Nephrology (ITUN); Nantes University Hospital; Nantes France"},{"name":"Inserm U1064; Nantes University Hospital; Nantes France"},{"name":"Thematic Research and Care Network RTRS \u201cCentaure\u201d; Universit\u00e9 de Strasbourg; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Le Borgne","sequence":"additional","affiliation":[{"name":"EA 4275 SPHERE; Nantes University; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Rimbert","sequence":"additional","affiliation":[{"name":"Plateforme CIMNA; CHU Nantes; Nantes France"},{"name":"Biotherapy Clinical Investigation; Center Nantes University Hospital; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick","family":"Gu\u00e9rif","sequence":"additional","affiliation":[{"name":"Institute for Transplantation, Urology and Nephrology (ITUN); Nantes University Hospital; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Malard-Castagnet","sequence":"additional","affiliation":[{"name":"LabEx Transplantex; Nantes France"},{"name":"Etablissement Fran\u00e7ais du Sang; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Foucher","sequence":"additional","affiliation":[{"name":"EA 4275 SPHERE; Nantes University; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Giral","sequence":"additional","affiliation":[{"name":"Institute for Transplantation, Urology and Nephrology (ITUN); Nantes University Hospital; Nantes France"},{"name":"Inserm U1064; Nantes University Hospital; Nantes France"},{"name":"EA 4275 SPHERE; Nantes University; Nantes France"},{"name":"LabEx Transplantex; Nantes France"},{"name":"Thematic Research and Care Network RTRS \u201cCentaure\u201d; Universit\u00e9 de Strasbourg; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"10.1111\/tri.13009-BIB0001|tri13009-cit-0001","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13009-BIB0002|tri13009-cit-0002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success","volume":"11","author":"Lodhi","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0003|tri13009-cit-0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1681\/ASN.2014040378","article-title":"Through a glass darkly: seeking clarity in preventing late kidney transplant failure","volume":"26","author":"Stegall","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13009-BIB0004|tri13009-cit-0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0005|tri13009-cit-0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: diagnosis and patho-genesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13009-BIB0006|tri13009-cit-0006","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/MOT.0b013e328355f12b","article-title":"Role of non-HLA antibodies in organ transplan-tation","volume":"17","author":"Dragun","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/tri.13009-BIB0007|tri13009-cit-0007","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2215\/CJN.00270106","article-title":"Mechanisms and role of HLA and non-HLA alloantibodies","volume":"1","author":"Tinckam","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.13009-BIB0008|tri13009-cit-0008","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MOT.0b013e3283636e55","article-title":"Non-HLA antibodies in solid organ trans-plantation: recent concepts and clinical relevance","volume":"18","author":"Dragun","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"Suppl. 1","key":"10.1111\/tri.13009-BIB0009|tri13009-cit-0009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1399-0039.2006.00764.x","article-title":"14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation","volume":"69","author":"Zachary","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1111\/tri.13009-BIB0010|tri13009-cit-0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoan-tibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/tri.13009-BIB0011|tri13009-cit-0011","first-page":"1019","article-title":"Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation","volume":"86","author":"Dragun","year":"2008","journal-title":"Trans-plantation"},{"key":"10.1111\/tri.13009-BIB0012|tri13009-cit-0012","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.humimm.2013.06.034","article-title":"Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation","volume":"74","author":"Reinsmoen","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1111\/tri.13009-BIB0013|tri13009-cit-0013","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13009-BIB0014|tri13009-cit-0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCRESAHA.113.300752","article-title":"Angiotensin receptor agonistic autoantibodies and hyperten-sion: preeclampsia and beyond","volume":"113","author":"Xia","year":"2013","journal-title":"Circ Res"},{"key":"10.1111\/tri.13009-BIB0015|tri13009-cit-0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0016|tri13009-cit-0016","article-title":"The clinicopathological relevance of pre-transplant anti-angiotensin II type 1 receptor antibodies in renal transplan-tation","author":"Lee","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13009-BIB0017|tri13009-cit-0017","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3343\/alm.2015.35.3.314","article-title":"Investigation of serum angiotensin II type 1 receptor antibodies at the time of renal allograft rejection","volume":"35","author":"Lee","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1111\/tri.13009-BIB0018|tri13009-cit-0018","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00467-015-3123-5","article-title":"Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies","volume":"30","author":"Pearl","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"Suppl. 1","key":"10.1111\/tri.13009-BIB0019|tri13009-cit-0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nep.12421","article-title":"Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation","volume":"20","author":"Jobert","year":"2015","journal-title":"Nephrology Carlton"},{"key":"10.1111\/tri.13009-BIB0020|tri13009-cit-0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/tri.12371","article-title":"The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes","volume":"27","author":"Banasik","year":"2014","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13009-BIB0021|tri13009-cit-0021","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/nep.12441","article-title":"C4d-negative antibody-mediated rejec-tion with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies","volume":"20","author":"Fuss","year":"2015","journal-title":"Nephrology Carlton"},{"key":"10.1111\/tri.13009-BIB0022|tri13009-cit-0022","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.transproceed.2014.09.096","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejec-tion in patients without preformed HLA-donor-specific antibody","volume":"46","author":"In","year":"2014","journal-title":"Trans-plant Proc"},{"key":"10.1111\/tri.13009-BIB0023|tri13009-cit-0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2017.06.004","article-title":"Circulating angiotensin type II receptor: possible marker for antibody mediated rejection after renal transplantation?","author":"Kimball","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1111\/tri.13009-BIB0024|tri13009-cit-0024","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/ijerph14050500","article-title":"The presence of anti-angiotensin II type-1 receptor anti-bodies adversely affect kidney graft outcomes","volume":"14","author":"Zhang","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1111\/tri.13009-BIB0025|tri13009-cit-0025","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0026|tri13009-cit-0026","first-page":"117","article-title":"Multi-state analysis of kidney transplant recipients outcome: a semi-Markov model for studying the role of pre-transplant sensitization against Angio-tensin II Type 1 receptor","volume":"155","author":"Gillaizeau","year":"2014","journal-title":"J Soc Fr Statistique"},{"key":"10.1111\/tri.13009-BIB0027|tri13009-cit-0027","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future direc-tions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0028|tri13009-cit-0028","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.TP.0000128167.60172.CC","article-title":"Natural history, risk factors, and impact of subclinical rejection in kidney trans-plantation","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/tri.13009-BIB0029|tri13009-cit-0029","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1600-6143.2006.01677.x","article-title":"Protocol biopsies in renal transplantation: insights into patient management and pathogenesis","volume":"7","author":"Mengel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0030|tri13009-cit-0030","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/ndt\/gft355","article-title":"When do we need competing risks methods for survival analysis in nephrology?","volume":"28","author":"Noordzij","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13009-BIB0031|tri13009-cit-0031","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1111\/tri.13009-BIB0032|tri13009-cit-0032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1111\/tri.13009-BIB0033|tri13009-cit-0033","unstructured":"Aalen O Johansen S An empirical transition matrix for non-homogeneous Markov chains based on censored observations 1978"},{"key":"10.1111\/tri.13009-BIB0034|tri13009-cit-0034","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team VA","year":"2014"},{"key":"10.1111\/tri.13009-BIB0035|tri13009-cit-0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-130-6-199903160-00016","article-title":"Assessing the generalizability of prognostic information","volume":"130","author":"Justice","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/tri.13009-BIB0036|tri13009-cit-0036","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2288-13-33","article-title":"External validation of a Cox prognostic model: principles and methods","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1111\/tri.13009-BIB0037|tri13009-cit-0037","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1600-6143.2005.00816.x","article-title":"Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation","volume":"5","author":"Cantarovich","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0038|tri13009-cit-0038","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/tri.12687","article-title":"Impact of de novo donor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation","volume":"29","author":"Malheiro","year":"2016","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13009-BIB0039|tri13009-cit-0039","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13009-BIB0040|tri13009-cit-0040","first-page":"218","article-title":"Pre-transplant angiotensin II type 1 receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period?","volume":"66","author":"Hern\u00e1ndez-M\u00e9ndez","year":"2014","journal-title":"Rev Invest Clin"},{"key":"10.1111\/tri.13009-BIB0041|tri13009-cit-0041","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ndt\/17.6.1081","article-title":"Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts","volume":"17","author":"Gough","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 3","key":"10.1111\/tri.13009-BIB0042|tri13009-cit-0042","first-page":"23","article-title":"Are AT1R antibodies as dangerous as HLA-DSAs in renal allografts?","volume":"15","author":"Cuevas","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13009-BIB0043|tri13009-cit-0043","doi-asserted-by":"crossref","first-page":"e006666","DOI":"10.1136\/bmjopen-2014-006666","article-title":"Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting","volume":"5","author":"Meerpohl","year":"2015","journal-title":"BMJ Open"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.13009","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.13009\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:40:15Z","timestamp":1641062415000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.13009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.13009","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10,5]]}}}